RxDoctor Payments Data

Joseph Williams, MD

Internal Medicine · West Columbia, SCNPI 1225038656

Payments from drug & device makers

$327in general payments, 2019–2025

Across 18 payments — averaging $18.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$82
  • Exact Sciences$59
  • Boehringer Ingelheim$36
  • Sumitomo Pharma America, Inc.$24
  • Lilly USA, LLC$24
  • Amgen$22
  • plus $80 from 5 others

What the payments were for

  • Food & beverage$327100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$327 in reported general payments places this provider in the 50th percentile of 1,498 internal medicine providers in South Carolina.

See all internal medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$59,015
Medicare patients
245
Services billed
835

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide40$69,428
MounjaroTirzepatide40$55,155
EliquisApixaban25$33,511
JanuviaSitagliptin Phosphate17$20,257
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$16,464
JardianceEmpagliflozin12$12,983
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$6,131
Albuterol Sulfate HfaAlbuterol Sulfate66$2,283
Atorvastatin Calcium263$2,060
Gabapentin60$1,495
Losartan Potassium121$1,228
Pregabalin16$1,216
Metoprolol Succinate75$1,027
Amlodipine Besylate169$950
Bupropion XlBupropion Hcl29$941

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$82$69,42840 claims
Lilly USA, LLCMounjaro$24$55,15540 claims
Boehringer IngelheimJardiance$36$12,98312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,498 internal medicine providers in South Carolina.

Other internal medicine in West Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →